Recruiting Eosinophilic Esophagitis Studies in Philadelphia
About Eosinophilic Esophagitis Clinical Trials in Philadelphia
Eosinophilic esophagitis (EoE) is a chronic allergic/immune condition where eosinophils accumulate in the esophagus, causing inflammation and difficulty swallowing. Prevalence has been increasing in recent decades. Treatment includes dietary elimination, proton pump inhibitors, and topical corticosteroids.
There are currently 2 eosinophilic esophagitis clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 95 participants. Research is being sponsored by Children's Hospital of Philadelphia, Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Eosinophilic Esophagitis Clinical Trials in Philadelphia — FAQ
Are there eosinophilic esophagitis clinical trials in Philadelphia?
Yes, there are 2 eosinophilic esophagitis clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What eosinophilic esophagitis treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for eosinophilic esophagitis.
Data updated October 16, 2026 from ClinicalTrials.gov